Skip to content
Men Under Microscope – Lifestyle
Home
Sample Page
Author:
Alector, Inc.
Alector to Participate in Upcoming Healthcare Conferences
September 3, 2026
Alector Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Alector Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis
April 29, 2026